Literature DB >> 3827417

Low serum cobalamin levels in primary degenerative dementia. Do some patients harbor atypical cobalamin deficiency states?

D S Karnaze, R Carmel.   

Abstract

Serum cobalamin (vitamin B12) levels were analyzed retrospectively in 17 patients with primary degenerative dementia and 11 with specific demonstrable causes of dementia (secondary dementia). The prevalence of low cobalamin levels was significantly increased in primary dementia (29% vs 0% in secondary dementia). Because typical findings of deficiency often seemed absent, we prospectively studied two other patients with primary dementia and low cobalamin levels. Neither of these two had megaloblastic anemia; one had a normal Schilling test while the other's was borderline. Despite this absence of the expected findings, the deoxyuridine suppression test gave biochemical evidence of cobalamin deficiency in both cases. Our survey of 28 patients thus established that low serum cobalamin levels are frequent in primary dementia. Our findings in the two prospectively studied cases (as well as in some of the patients in the survey) indicate that these levels are associated in at least some cases with an atypical deficiency state rather than with disorders such as pernicious anemia. Such atypical deficiency states cannot be identified by classic hematological criteria or by the Schilling test.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3827417

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  7 in total

Review 1.  Nutritional supplements in the ambulatory geriatric population. Should they be recommended?

Authors:  M L Freedman
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

Review 2.  Vitamin B12 deficiency presenting as an acute confusional state: a case report and review of literature.

Authors:  D Kibirige; C Wekesa; M Kaddu-Mukasa; M Waiswa
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

Review 3.  Vitamin B12 replacement. To B12 or not to B12?

Authors:  M D Delva
Journal:  Can Fam Physician       Date:  1997-05       Impact factor: 3.275

4.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

5.  Vitamin B12 and folate concentrations in serum and cerebrospinal fluid of neurological patients with special reference to multiple sclerosis and dementia.

Authors:  T Q Nijst; R A Wevers; H C Schoonderwaldt; O R Hommes; A F de Haan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-11       Impact factor: 10.154

6.  Vitamin B12-induced reduction of platelet monoamine oxidase activity in patients with dementia and pernicious anaemia.

Authors:  B Regland; C G Gottfries; L Oreland
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

Review 7.  Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II.

Authors:  Ralph Carmel
Journal:  Am J Clin Nutr       Date:  2011-05-18       Impact factor: 7.045

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.